Why the study?
Hypertension affects over 1.5 billion people worldwide and increases the risk of cardiovascular disease events and death, prompting an expert panel to compile lifestyle management recommendations as a first-line strategy to prevent and control hypertension in adulthood.
Does lifestyle management prevent and control hypertension in adulthood?
Does lifestyle management prevent and control hypertension in adulthood?
This position paper provides comprehensive, evidence-based lifestyle management recommendations as a first-line strategy for the prevention and control of hypertension.
Emphasize lifestyle interventions as first-line for adult hypertension prevention and control; reinforces consensus on their continuation with pharmacotherapy.
Hypertension, defined as persistently elevated systolic blood pressure (SBP) >140 mmHg and/or diastolic blood pressure (DBP) at least 90 mmHg (International Society of Hypertension guidelines), affects over 1.5 billion people worldwide. Hypertension is associated with increased risk of cardiovascular disease (CVD) events (e.g. coronary heart disease, heart failure and stroke) and death. An international panel of experts convened by the International Society of Hypertension College of Experts compiled lifestyle management recommendations as first-line strategy to prevent and control hypertension in adulthood. We also recommend that lifestyle changes be continued even when blood pressure-lowering medications are prescribed. Specific recommendations based on literature evidence are summarized with advice to start these measures early in life, including maintaining a healthy body weight, increased levels of different types of physical activity, healthy eating and drinking, avoidance and cessation of smoking and alcohol use, management of stress and sleep levels. We also discuss the relevance of specific approaches including consumption of sodium, potassium, sugar, fibre, coffee, tea, intermittent fasting as well as integrated strategies to implement these recommendations using, for example, behaviour change-related technologies and digital tools.
No takes yet. Share an insight, caveat, or question.
Charchar et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: